Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype

作者: G. CASTAMAN , S. H. GIACOMELLI , P. JACOBI , T. OBSER , U. BUDDE

DOI: 10.1111/J.1538-7836.2010.03971.X

关键词: EndocrinologyMutationHeterozygote advantageGene mutationChemistryPhenotypeRecombinant DNAVon Willebrand factorMutantVon Willebrand diseaseInternal medicine

摘要: Summary. Background: von Willebrand disease (VWD) type Normandy (VWD 2N) is caused by mutations at the factor (F)VIII-binding site of von (VWF), located in D′and D3 domains on N-terminus mature VWF. The R854Q mutation most frequent cause this phenotype. Objectives: We report characterization a homozygous VWD 2N mutation, R854W, detected patient with severe VWD Methods: The plasma VWF phenotype was studied, transient expression recombinant mutant full-length 293 EBNA cells performed, and results were compared those obtained wild-type (WT) Furthermore, also examined HEK293 cells, which form Weibel–Palade body-like granules when transfected WT Results: The multimer analysis showed lack typical triplet structure, presence central band only, relative decrease high molecular mass multimers. Homozygous R854W resulted normal amounts cellular VWF, but reduction secretion into medium. Severe reductions FVIII binding to glycoprotein Ib activity collagen secreted W854 observed, reproduced phenotypic parameters In failed granules. Conclusions: Our demonstrate that D′ domain induces impaired protein, thereby explaining patient.

参考文章(27)
M Nishino, JP Girma, C Rothschild, E Fressinaud, D Meyer, New variant of von Willebrand disease with defective binding to factor VIII. Blood. ,vol. 74, pp. 1591- 1599 ,(1989) , 10.1182/BLOOD.V74.5.1591.1591
Simon Allen, Adel M. Abuzenadah, Joanna L. Blagg, Joanna Hinks, I. Mandy Nesbitt, Anne C. Goodeve, Turkiz Gursel, Jørgen Ingerslev, Ian R. Peake, Martina E. Daly, Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood. ,vol. 95, pp. 2000- 2007 ,(2000) , 10.1182/BLOOD.V95.6.2000
Sylvie Jorieux, Edith Fressinaud, Jenny Goudemand, Christine Gaucher, Dominique Meyer, Claudine Mazurier, , Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment. Blood. ,vol. 95, pp. 3139- 3145 ,(2000) , 10.1182/BLOOD.V95.10.3139
C. J. SCHOOTEN, P. TJERNBERG, E. WESTEIN, V. TERRAUBE, G. CASTAMAN, J. A. MOURIK, M. J. HOLLESTELLE, H. L. VOS, R. M. BERTINA, H. M. BERG, J. C. J. EIKENBOOM, P. J. LENTING, C. V. DENIS, Cysteine-mutations in von Willebrand factor associated with increased clearance. Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 2228- 2237 ,(2005) , 10.1111/J.1538-7836.2005.01571.X
G. R. Standen, C. Mazurier, C. Gaucher, A. Cumming, S. Keeney, J. Bidwell, D. J. Bowen, Type 2N von Willebrand Disease: Rapid Genetic Diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F) – Detection of a Novel Candidate Type 2N Mutation: C2810T (R854W) Thrombosis and Haemostasis. ,vol. 80, pp. 32- 36 ,(1998) , 10.1055/S-0037-1615134
Zaverio M Ruggeri, Ileana Forza, Maria T Canciani, Pier Mannuccio Mannucci, Patrizia Marchese, Augusto B Federici, Jerry Ware, A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica. ,vol. 89, pp. 77- 85 ,(2004) , 10.3324/%X
Armin J Reininger, Harry FG Heijnen, Hannah Schumann, Hanno M Specht, Wolfgang Schramm, Zaverio M Ruggeri, Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress Blood. ,vol. 107, pp. 3537- 3545 ,(2006) , 10.1182/BLOOD-2005-02-0618
Ya-Ping Wu, Tom Vink, Marion Schiphorst, G. Henrita van Zanten, Martin J. W. IJsseldijk, Philip G. de Groot, Jan J. Sixma, Platelet Thrombus Formation on Collagen at High Shear Rates Is Mediated by von Willebrand Factor–Glycoprotein Ib Interaction and Inhibited by von Willebrand Factor–Glycoprotein IIb/IIIa Interaction Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 20, pp. 1661- 1667 ,(2000) , 10.1161/01.ATV.20.6.1661